Tarriff Scott
CEO and President at EAGLE PHARMACEUTICALS, INC.
- Sold, on record
- $24.4M
- Dollars the filings state
- Form 4 sales
- 18
- Latest Nov 2, 2023
- Form 144 notices
- 5
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- EAGLE PHARMACEUTICALS, INC.CEO and President
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale EAGLE PHARMACEUTICALS, INC.No planMay 15 2023
Sold 45,000 shares at $20.68 ($931k)
Tarriff Scott, CEO
No 10b5-1 planSold 2.7% of holdings ($33.9M position)1.6M shares leftFirst sale on recordFollows a Form 144Filing
- 2 Form 4 sale EAGLE PHARMACEUTICALS, INC.No planMay 16 +1 day
Sold 15,000 shares at $19.98 ($300k)
Tarriff Scott, CEO
No 10b5-1 planSold 2.5% of holdings ($12M position)587,311 shares leftFollows a Form 144Filing
- 3 Form 144 notice EAGLE PHARMACEUTICALS, INC.NoticeOct 2 +139 days
Filed to sell 9,511 shares ($150k)
Tarriff Scott, CEO and President
10b5-1 planFiling
- 4 Form 144 notice EAGLE PHARMACEUTICALS, INC.NoticeOct 3 +1 day
Filed to sell 10,734 shares ($155k)
Tarriff Scott, CEO and President
10b5-1 planFiling
- 5 Form 4 sale EAGLE PHARMACEUTICALS, INC.RoutineOct 3 same day
Sold 20,245 shares at $14.82 ($300k)
Tarriff Scott, CEO
10b5-1 planSold 3.4% of holdings ($8.7M position)567,066 shares leftFollows a Form 144Filing
- 6 Form 144 notice EAGLE PHARMACEUTICALS, INC.NoticeNov 1 +29 days
Filed to sell 10,925 shares ($150k)
Tarriff Scott, CEO and President
10b5-1 plan0.5x usual sizeFiling
- 7 Form 144 notice EAGLE PHARMACEUTICALS, INC.NoticeNov 2 +1 day
Filed to sell 10,694 shares ($150k)
Tarriff Scott, CEO and President
10b5-1 plan0.5x usual sizeFiling
- 8 Form 4 sale EAGLE PHARMACEUTICALS, INC.RoutineNov 2 same day
Sold 21,619 shares at $13.84 ($299k)
Tarriff Scott, CEO
10b5-1 planSold 3.8% of holdings ($7.9M position)545,447 shares left1.1x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (23)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2023 | EAGLE PHARMACEUTICALS, INC. | CEO | Form 4 sale | 21,619 | $299k | 3.8% | Routine | SEC |
| Nov 2, 2023 | EAGLE PHARMACEUTICALS, INC. | CEO and President | Form 144 notice | 10,694 | $150k | Notice | SEC | |
| Nov 1, 2023 | EAGLE PHARMACEUTICALS, INC. | CEO and President | Form 144 notice | 10,925 | $150k | Notice | SEC | |
| Oct 3, 2023 | EAGLE PHARMACEUTICALS, INC. | CEO | Form 4 sale | 20,245 | $300k | 3.4% | Routine | SEC |
| Oct 3, 2023 | EAGLE PHARMACEUTICALS, INC. | CEO and President | Form 144 notice | 10,734 | $155k | Notice | SEC | |
| Oct 2, 2023 | EAGLE PHARMACEUTICALS, INC. | CEO and President | Form 144 notice | 9,511 | $150k | Notice | SEC | |
| May 16, 2023 | EAGLE PHARMACEUTICALS, INC. | CEO | Form 4 sale | 15,000 | $300k | 2.5% | No plan | SEC |
| May 15, 2023 | EAGLE PHARMACEUTICALS, INC. | CEO | Form 4 sale | 45,000 | $931k | 2.7% | No plan | SEC |
| May 11, 2023 | EAGLE PHARMACEUTICALS, INC. | CEO and President | Form 144 notice | 60,000 | $1.3M | Notice | SEC | |
| Apr 1, 2019 | EAGLE PHARMACEUTICALS, INC. | CEO | Form 4 sale | 24,975 | $1.3M | 1.6% | Plan not stated | SEC |
| Mar 1, 2019 | EAGLE PHARMACEUTICALS, INC. | CEO | Form 4 sale | 24,428 | $1.3M | 1.6% | Plan not stated | SEC |
| Feb 1, 2019 | EAGLE PHARMACEUTICALS, INC. | CEO | Form 4 sale | 30,085 | $1.2M | 1.9% | Plan not stated | SEC |
| Jan 3, 2019 | EAGLE PHARMACEUTICALS, INC. | CEO | Form 4 sale | 31,569 | $1.2M | 2.0% | Plan not stated | SEC |
| Apr 1, 2016 | EAGLE PHARMACEUTICALS, INC. | President and CEO | Form 4 sale | 30,765 | $1.2M | 2.2% | Plan not stated | SEC |
| Mar 1, 2016 | EAGLE PHARMACEUTICALS, INC. | President and CEO | Form 4 sale | 19,780 | $1.3M | 1.4% | Plan not stated | SEC |
| Feb 1, 2016 | EAGLE PHARMACEUTICALS, INC. | President and CEO | Form 4 sale | 18,360 | $1.2M | 1.3% | Plan not stated | SEC |
| Jan 4, 2016 | EAGLE PHARMACEUTICALS, INC. | President and CEO | Form 4 sale | 14,549 | $1.2M | 1.0% | Plan not stated | SEC |
| Dec 1, 2015 | EAGLE PHARMACEUTICALS, INC. | President and CEO | Form 4 sale | 14,050 | $1.2M | 1.0% | Plan not stated | SEC |
| Nov 2, 2015 | EAGLE PHARMACEUTICALS, INC. | President and CEO | Form 4 sale | 19,339 | $1.2M | 1.3% | Plan not stated | SEC |
| Oct 1, 2015 | EAGLE PHARMACEUTICALS, INC. | President and CEO | Form 4 sale | 17,878 | $1.2M | 1.2% | Plan not stated | SEC |
| Sep 1, 2015 | EAGLE PHARMACEUTICALS, INC. | President and CEO | Form 4 sale | 16,245 | $1.2M | 1.1% | Plan not stated | SEC |
| Aug 3, 2015 | EAGLE PHARMACEUTICALS, INC. | President and CEO | Form 4 sale | 13,000 | $1.3M | 0.8% | Plan not stated | SEC |
| Jul 1, 2015 | EAGLE PHARMACEUTICALS, INC. | President and CEO | Form 4 sale | 135,710 | $6.3M | 8.1% | Plan not stated | SEC |